David Spiegelhalter on Twitter: "Predict Prostate launched today! https://t.co/E6f9hh0sTY - good to be linked from the Sun https://t.co/tA1sciElIN https://t.co/27EJmLcHdm" / Twitter
![Withdrawn] [Withdrawn] Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing - GOV.UK Withdrawn] [Withdrawn] Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing - GOV.UK](https://assets.publishing.service.gov.uk/government/uploads/system/uploads/image_data/file/50828/cases_crude_prostate_1_2011_2013.jpg)
Withdrawn] [Withdrawn] Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing - GOV.UK
![Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice](https://bjgp.org/content/bjgp/71/706/e364/F1.large.jpg)
Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice
![Favorable vs Unfavorable Intermediate-Risk Prostate Cancer: A Review of the New Classification System and Its Impact on Treatment Recommendations Favorable vs Unfavorable Intermediate-Risk Prostate Cancer: A Review of the New Classification System and Its Impact on Treatment Recommendations](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/034af9cccc61ea5eaf376b54f4f5f7a90ec04dca-765x477.png?fit=crop&auto=format)
Favorable vs Unfavorable Intermediate-Risk Prostate Cancer: A Review of the New Classification System and Its Impact on Treatment Recommendations
![Withdrawn] [Withdrawn] Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing - GOV.UK Withdrawn] [Withdrawn] Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing - GOV.UK](https://assets.publishing.service.gov.uk/government/uploads/system/uploads/image_data/file/44717/deaths_crude_prostate-1.png)
Withdrawn] [Withdrawn] Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing - GOV.UK
![A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc](https://www.urotoday.com/images/stories/Beyond_the_Abstract/bta_zhu_fig1b.jpg)
A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam, "Beyond the Abstract," by Xiaoye Zhu, MD and Monique J. Roobol, PhD, MSc
![PDF) Rotterdam Prostate Cancer Risk Calculator: Development and Usability Testing of the Mobile Phone App PDF) Rotterdam Prostate Cancer Risk Calculator: Development and Usability Testing of the Mobile Phone App](https://www.researchgate.net/profile/Nuno-Pereira-Azevedo/publication/312410487/figure/fig4/AS:667646974504973@1536190851928/Screenshots-of-the-Rotterdam-Prostate-Cancer-Risk-Calculator-app-showing-About_Q320.jpg)
PDF) Rotterdam Prostate Cancer Risk Calculator: Development and Usability Testing of the Mobile Phone App
![Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI Article of the Week: ERSPC risk calculators significantly outperform the PCPT 2.0 in the prediction of PCa – BJUI](https://www.bjuinternational.com/wp-content/uploads/2016/11/AOTWNov-2-FI.jpg)